why choose us

Clinical Trials Search

Showing 17,820 of 132,963 result(s)
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: Intravenous infusion of AB248: CD8+ T cell selective interleukin-2 investigational drug

Date: 2022-11-30

Peripheral Nerve Stimulation Therapy for Atrial Fibrillation

Status: NOT_YET_RECRUITING

Condition: Atrial Fibrillation

Interventions: peripheral nerve stimulation via wrist-worn device

Date: 2022-11-30

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Status: Completed

Condition: Recurrent Lung Non-Small Cell Carcinoma

Interventions: Undergo collection of blood samples

Date: 2022-11-30

Study of AV-1959, an Amyloid Beta Vaccine

Status: Completed

Condition: Alzheimer Disease

Interventions: Three doses of AV-1959D administered as a sterile suspension via intradermal injection

Date: 2022-11-30

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Status: Completed

Condition: B-cell Lymphoma

Interventions: CTX112 (CD19-directed T-cell immunotherapy comprised of allogeneic T cells genetically modified ex vivo using CRISPR-Cas9 gene editing components)

Date: 2022-11-30

The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Status: Completed

Condition: Prosocial Behavior

Interventions: Single dose of LSD (50 µg) will be administered in a small amount of alcohol (ethanol, 2ml;95% Vol.) orally.

Date: 2022-11-30

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

Status: Completed

Condition: Hemorrhagic Stroke

Interventions: Electronic health record best practice alert which suggests measurement of LDL and HbA1c (in-patient) and referrals to sleep study and audiology (out-

Date: 2022-11-30

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Status: Completed

Condition: Mood Disorders

Interventions: Pharmacogenetic genotyping provides personalised medication advice on dosage and choice of currently available and legally approved medication based o

Date: 2022-11-30

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

Status: Completed

Condition: Univentricular Heart

Interventions: Autologous IPSCL

Date: 2022-11-30

Comparing Cooling and;or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Status: Completed

Condition: Malignant Solid Neoplasm

Interventions: Undergo collection of blood, plasma, and serum

Date: 2022-11-30